How to get URL link on X (Twitter) App
https://twitter.com/MylesMcNulty/status/1615254393011544064There are many stale holders who have been underwater for 18+ months, who will be happy to take some cash out now, in this ongoing cost of living crisis. That is understandable.
https://twitter.com/MylesMcNulty/status/1592101365299429377Volume returning really nicely to the small cap space, which is creating excellent trading conditions.
https://twitter.com/MylesMcNulty/status/1494653872610152449@BushveldMin_Ltd controls one of the largest and highest grade vanadium resource bases globally, at 549 million tonnes.
https://twitter.com/MylesMcNulty/status/1484564887682625542#AVCT has four platform technologies:
https://twitter.com/TheEthicalTout/status/1483026203577663489For each of its past two FYs, #APTA has generated no more than £1m in revenue.
https://twitter.com/MylesMcNulty/status/1465219470310400002On Monday, #AVCT announced that it had received FDA approval for its Investigational New Drug ('IND') application, to expand its Phase I clinical trial for AVA6000, into trial sites in the US.
https://twitter.com/MylesMcNulty/status/1441325425720844288At the current tin price ⬆️, Uis running at nameplate capacity of 1,200 tpa (post ongoing expansion works) would be generating circa £26m EBITDA on circa £36m revs.
https://twitter.com/downunderfutbol/status/1410600840658776073Amy Turner, co-author: "RAS really is the Holy Grail of therapeutic targets. The fact that it has previously been termed 'undruggable' has allowed us to demonstrate the huge impact that our Affimer technology can have when it comes to treating challenging pathologies."
https://twitter.com/MylesMcNulty/status/1398216164095008768As per the Retweet ⬆️, this continued on-field success is critical for the commercial success of @guildesports over the long-term.